Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Apr 14, 2026
Fastenal (FAST) Q1 2026 Earnings: Solid Growth Amid Margin Pressures

Fastenal (FAST) Q1 2026 Earnings: Solid Growth Amid Margin Pressures

Key Takeaways

  • Fastenal reported Q1 2026 net sales of $2.20 billion, up 12.4% year-over-year on a daily sales basis, beating consensus estimates of $2.19 billion.
  • Diluted EPS came in at $0.30, meeting analyst expectations and rising 13.6% from $0.26 in Q1 2025, adjusted for the two-for-one stock split.
  • Operating margin expanded 20 basis points to 20.3%, driven by sales leverage despite gross margin contraction from price/cost headwinds.
  • Strong cash flow generation at $378.4 million (111.4% of net income) supported $296 million returned to shareholders via dividends and repurchases.
  • Digital sales through FMI (FASTBin/FASTVend) reached 44.9% of total sales, up 150 basis points year-over-year.
  • Shares fell about 7% post-earnings amid concerns over ongoing pricing challenges and a "challenging" Q2 outlook.

Why Fastenal's Q1 Results Matter for Investors

Fastenal Company (FAST), a key player in distributing industrial and construction supplies, shared its first quarter 2026 earnings on April 13, 2026, covering the period ended March 31, 2026. In my view, this report stands out because it shows how well the company is capturing market share in a cyclical sector, especially with U.S. manufacturing activity improving—the PMI averaged 52.6. I always pay close attention to indicators like sustained demand recovery, efficiencies from technologies such as FASTBin/FASTVend machines (FMI), and the ability to hold margins against inflation and tariffs. With contract customers making up 75.4% of sales and growing 14.6% on a daily basis, these numbers highlight Fastenal's emphasis on major accounts and digital channels, which directly impacts its valuation as a high-ROIC business that trades at a premium.

Breaking Down the Reported Numbers

Fastenal posted net sales of $2,201.7 million for Q1 2026, marking a 12.4% rise from $1,959.4 million in Q1 2025, with average daily sales climbing to $34.9 million from $31.1 million—both periods included 63 business days. This came in ahead of the consensus revenue estimate of $2.19 billion. The growth reflected market share gains, a 3.5 percentage point pricing uplift, a 0.6 percentage point foreign exchange tailwind, robust contract signings, and strength across end markets like manufacturing (+12.3%) and non-residential construction (+17.2%).

Diluted EPS landed at $0.30, right on the $0.30 consensus mark and up 13.6% year-over-year from $0.26. Net income increased 13.8% to $339.8 million. The gross profit margin slipped 50 basis points to 44.6%, hit by about 50 basis points in net price/cost headwinds from tariffs and slower pricing, plus transportation costs, rebates, and a shift toward lower-margin large customers. Operating income grew 13.6% to $447.6 million, yielding a 20.3% margin (up 20 basis points), thanks to SG&A leverage that shaved 70 basis points to 24.3%. Operating cash flow jumped 44.3% to $378.4 million. Management didn't provide formal numerical guidance but noted ongoing investments and a target of 28,000-30,000 manufacturing equivalent units (MEUs) for FMI signings. I also checked this using Tickeron’s AI Screener to gauge how FAST stacks up against industry peers on these metrics.

Market Reaction and What Investors Are Focusing On

Even with EPS meeting expectations and revenues slightly topping forecasts, Fastenal (FAST) shares declined about 7% on April 13, 2026, closing down 6.85% amid wider market pressures and emphasis on gross margin erosion tied to tariff costs and pricing delays. Pre-market trading showed a 2.4% drop, and sentiment was cooled by the CEO's description of Q2 as "challenging" due to lingering headwinds. From what I see, investors viewed the quarter as strong on execution but flagged margin risks, prompting some profit-taking near 52-week highs.

Looking Ahead: Outlook and Metrics to Watch

Fastenal's path forward depends on managing price/cost dynamics with tariff uncertainty and supplier inflation in play. Management is pushing pricing actions for neutrality, but lags affected Q1 gross margins; benefits from fastener expansions will start anniversarying early in Q2, which could provide some relief. Broader industrial demand looks encouraging, with PMI above 50 for three straight months—a pattern that has historically led to upticks 3-4 months later.

One thing that stands out is tracking FMI signings, with a 2026 goal of 28,000-30,000 MEUs, alongside digital sales aiming for 66% of total. Key account wins and onsite locations—those generating $50k+ monthly are up 16.3% year-over-year—will be telling. Capex is set at $310-$330 million for the year (about 3.5% of sales), higher than 2025's $230.6 million, to support hub upgrades, trucking, and IT.

I'm watching Q2 sales trends closely, as the CEO highlighted ongoing challenges; the ramp-up in heavy incentive comp will anniversary in Q2, potentially boosting operating margins. End-market splits, like heavy manufacturing at 14.1% daily sales growth in Q1 versus softer areas, plus working capital efficiency (trade working capital up 6.2%), will indicate if cash generation holds up to support returns—87% of Q1 net income went back to shareholders.

Tools I Use: Tickeron’s AI Screener

In my own research, I rely on Tickeron’s AI Screener, an AI-powered tool for discovering stocks and ETFs. It lets me filter thousands of names using technical patterns, fundamentals, trends, volatility, and AI signals—customizable by industry, market cap, indicators, price patterns, and more. This helps spot trade ideas, breakouts, and opportunities far quicker than manual scans, and I've found it particularly useful for dissecting companies like Fastenal (FAST) in context.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: FAST

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for FAST turns positive, indicating new upward trend

FAST saw its Momentum Indicator move above the 0 level on September 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In 60 of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at 72%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for FAST just turned positive on September 22, 2026. Looking at past instances where FAST's MACD turned positive, the stock continued to rise in 35 of 49 cases over the following month. The odds of a continued upward trend are 71%.

FAST moved above its 50-day moving average on October 01, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where FAST advanced for three days, in 213 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 60 cases where FAST's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 50%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FAST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.

FAST broke above its upper Bollinger Band on September 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for FAST entered a downward trend on September 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 30 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. FAST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 58 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 67, placing this stock slightly better than average.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.245) is normal, around the industry mean (7.841). P/E Ratio (43.162) is within average values for comparable stocks, (134.538). Projected Growth (PEG Ratio) (3.357) is also within normal values, averaging (2.538). Dividend Yield (0.019) settles around the average of (0.009) among similar stocks. P/S Ratio (6.447) is also within normal values, averaging (3.013).

Notable companies

The most notable companies in this group are Fastenal Co (NASDAQ:FAST).

Industry description

Electronics distributors are companies that are involved in distribution of one or more of the following: electronic components, computer products/ peripherals and software products & services. Several electronics distributors are also becoming the point of contact for technical/pre- & post-sale support in many cases, in an attempt to bolster their position in the market. Tariffs and/or cross-border trade barriers are some of the potential threats to the electronics supply chain, but that could also potentially lead to re-directing to markets where tariffs/restrictions are lower depending on demand. The industry is also vulnerable in the event of economic slowdowns. Arrow Electronics, Inc., SYNNEX Corporation and Versum Materials, Inc. are some of the major electronics distributors in the U.S.

Market Cap

The average market capitalization across the Electronics Distributors Industry is 10.86B. The market cap for tickers in the group ranges from 149 to 59.14B. GWW holds the highest valuation in this group at 59.14B. The lowest valued company is AEYGQ at 149.

High and low price notable news

The average weekly price growth across all stocks in the Electronics Distributors Industry was 3%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 15%. WATR experienced the highest price growth at 12%, while WSO experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Electronics Distributors Industry was -19%. For the same stocks of the Industry, the average monthly volume growth was 19% and the average quarterly volume growth was -15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 55
Price Growth Rating: 52
SMR Rating: 67
Profit Risk Rating: 67
Seasonality Score: 42 (-100 ... +100)
View a ticker or compare two or three
FAST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of industrial hardware supply stores

Industry ElectronicsDistributors

Industry
Wholesale Distributors
Address
2001 Theurer Boulevard
Phone
+1 507 454-5374
Employees
24489
Web
https://www.fastenal.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.